Comparison of Two Dosages of Heparin Before Extracorporeal Circulation

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Extracorporeal Circulation; Complications

Interventions

DIAGNOSTIC_TEST

ACT (Activated Clotting Time)

Measure of ACT in the two arms in order to determine if injection of heparin based on ideal weight is better or not than those one on real weight.

DRUG

Heparin

300 IU of heparin

Trial Locations (1)

Clinique Saint-Luc of Bouge, Namur